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Background: Benzodiazepines are often prescribed long-term inappropriately. We aimed to systematically review
and meta-synthesise qualitative studies exploring clinicians’ experiences and perceptions of benzodiazepine
prescribing to build an explanatory model of processes underlying current prescribing practices.
Methods: We searched seven electronic databases for qualitative studies in Western primary care settings
published in a European language between January 1990 and August 2011 analysing GP or practice nurse
experiences of benzodiazepine prescribing. We assessed study quality using the Critical Appraisal Skills Programme
Checklist. We analysed findings using thematic synthesis.
Results: We included eight studies from seven countries published between 1993 and 2010. Benzodiazepine
prescribing decisions are complex, uncomfortable, and demanding, taken within the constraints of daily general
practice. Different GPs varied in the extent to which they were willing to prescribe benzodiazepines, and individual
GPs’ approaches also varied. GPs were ambivalent in their attitude towards prescribing benzodiazepines and
inconsistently applied management strategies for their use. This was due to the changing context of prescribing,
differing perceptions of the role and responsibility of the GP, variation in GPs’ attitudes to benzodiazepines,
perceived lack of alternative treatment options, GPs’ perception of patient expectations and the doctor-patient
relationship. GPs faced different challenges in managing initiation, continuation and withdrawal of benzodiazepines.
Conclusion: We have developed a model which could be used to inform future interventions to improve
adherence to benzodiazepine prescribing guidance and improve prescribing through education and training of
professionals on benzodiazepine use and withdrawal, greater provision of alternatives to drugs, reflective practice,
and better communication with patients.
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Inappropriate prescribingBackground
Benzodiazepines are used to treat conditions such as in-
somnia, anxiety and chronic back pain. They have con-
siderable adverse effects including memory disruption,
increased risk of accidents and falls, and dependence
[1,2]. Despite guidance advocating use of psychological
treatments first-line before drug treatment for insomnia* Correspondence: nsiriwardena@lincoln.ac.uk
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stated.[3], and short-term use of drugs when these are used
[4,5], numerous studies have shown that benzodiaze-
pines are being overprescribed for extended periods
[6-8] in many countries. For example, a review encom-
passing studies of benzodiazepine use in primary care in
European and other countries concluded that “the use of
benzodiazepines in the long-term is a very common
phenomenon” [9]. Many have questioned why this is the
case, and what influences clinicians’ decisions whether
or not to initiate, continue or withdraw a benzodiazepine
prescription.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Medline search strategy
Line
number
Search term
1 Qualitative
2 Interview*
3 Focus group*
4 Theme*
5 Experience*
6 MH qualitative research
7 MH interviews as topic+
8 MH attitude of health personnel
9 Attitude*
10 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9
11 MH benzodiazepines+
12 Benzodiazepine*
13 MH anti-anxiety agents
14 MH hypnotics and sedatives
15 z-drug*
16 z drug*
17 BZD
18 Anti-anxiety agent*
19 Anti anxiety agent*
20 Antianxiety agent*
21 Non-benzodiazepine*
22 Nonbenzodiazepine*
23 Non benzodiazepine*
24 Temazepam
25 Nitrazepam
26 Lormetazepam
27 Zopiclone
28 Zaleplon
29 Zolpidem
30 Eszopiclone
31 S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18
OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR
S26 OR S27 OR S28 OR S29 OR S30
32 MH general practice+
33 MH general practitioners
34 MH physicians, family
35 MH physicians, primary care
36 MH nurses+
37 General practi*
38 Family practi*
39 Family doctor*
40 Primary care
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and practices [10], partly explained by patient demograph-
ics, clinician attributes and differences in general practice
organisation [10-15]. Previous research has also demon-
strated that clinicians’ attitudes and experiences affect
their adherence to clinical guidelines [16].
We aimed to explore clinicians’ experiences and percep-
tions of primary care benzodiazepine prescribing, and to
build an explanatory model of the processes underlying
clinicians’ benzodiazepine prescribing using a meta-
synthesis of qualitative studies.
Methods
We conducted a systematic review of qualitative studies
exploring clinicians’ experiences and perceptions of pri-
mary care benzodiazepine prescribing and undertook a
‘meta-synthesis’ of these studies. ‘Meta-synthesis’ is “a
family of methodological approaches to developing new
knowledge based on rigorous analysis of existing qualita-
tive research findings,” [17,18] used to synthesise and
build upon these [16,19]. We used a ‘thematic synthesis’
approach to meta-synthesis [20] (see ‘data synthesis’ sec-
tion below) in order to improve our understanding, and
to inform policy and practice relating to primary care
benzodiazepine prescribing [19,21,22].
Search strategy
We systematically searched seven databases for relevant
papers: MEDLINE, CINAHL, Social Science Citation
Index, Science Citation Index, PsycINFO, Sociological
Abstracts and AMED. We adapted our search strategy
for MEDLINE for the other databases (Table 1). All da-
tabases were searched by October 2011.
Inclusion and exclusion criteria
Studies were included if: they involved qualitative ana-
lysis of GP or practice nurse experiences of prescribing
benzodiazepines; published between January 1990 and
August 2011 to ensure relevance to current practice and
the historical context of benzodiazepine prescribing;
published in a European language; conducted in Europe,
the United States, Australia or New Zealand; and in a
primary care setting. We excluded quantitative studies
published outside these dates, languages and settings.
We identified eight papers meeting these inclusion/ex-
clusion criteria from 1110 potential papers after remov-
ing duplicates, examining the titles and abstracts (where
available) or full papers (where relevance was unclear)
and references of included papers (Figure 1).
Data extraction and quality assessment
Two researcher pairs (SA and HC; CS and SYC) inde-
pendently extracted data on study aims, setting, sample,
theoretical perspective, data collection method and
Table 1 Medline search strategy (Continued)
41 Nurse*
42 S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39
OR S40 OR S41
43 S10 AND S31 AND S42 + Limiters: 1990 – 2011
*a wildcard search for any words which begin with the letters that precede
the asterisk.
+the search term has been `exploded' to include all references indexed to that
term and narrower terms beneath it.
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Appraisal Skills Programme (CASP) qualitative research
checklist focusing on design, sampling, data collection,
reflexivity, ethics, data analysis, findings and the value of
the research [23]. Agreement on quality ratings was
achieved through discussion to reach a consensus where
there was initial disagreement on whether a particular
criterion had been met.Figure 1 Study selection process.Data synthesis
‘Thematic synthesis’ was initially undertaken by the re-
searcher pairs in three stages. Firstly we carried out line-
by-line inspection of study ‘results’ to identify codes
based on the meaning and content of each line. Second,
we organised codes into a hierarchy of broader descrip-
tive themes supported by NVivo 8 [20]. Finally, we de-
veloped analytic themes to build a model which sought
to ‘go beyond’ the findings of the original papers to dir-
ectly address the research question [20]. At each stage
codes and themes were discussed to ensure consistency
and agreement and the final synthesis was conducted by
the wider multidisciplinary team with backgrounds in
psychology, sociology and medicine.
Results
Data extraction
Eight studies were included from seven countries pub-
lished between 1993 and 2010 (Table 2). These were based
Table 2 Description of studies included in the review
Title and authors Year of
publication
Country Aims Sample Method of data collection Method of data analysis Theoretical
perspective
Anthierens et al., The
lesser evil? Initiating a
benzodiazepine
prescription in general
practice: a qualitative
study on GPs’
perspectives
2007 Belgium To investigate the views of
GPs on why they initiate
benzodiazepine prescriptions
and their views about non-
medical alternatives
35 GPs from a variety of
practice settings (urban/rural)
5 focus groups Focus groups were audio
taped and transcribed
verbatim. Analysed by 3
researchers using systematic
content analysis. Themes were
derived directly from the data
rather than through an a priori
framework. Also did deviant
case analysis
Phenomenological.
Researchers doing
the analysis were
from different
disciplines - psych-
ologist, sociologist
and GP
Cook et al., Physicians’
perspectives on
prescribing
benzodiazepines for
older adults: a
qualitative study
2007 USA “To understand factors
influencing chronic use of
benzodiazepines in older
adults” (p303)
33 primary care physicians in
the Philadelphia area. Sought
a range of levels of experience
and practice settings
Semi-structured interviews Interviews were audio taped
and transcribed verbatim.
Coded by a multidisciplinary
team. 28 were face-to-face and
5 were telephone interviews.
Used narrative analysis
Unclear
Damestoy et al.,
Prescribing psychotropic
medication for elderly
patients: some
physicians’ perspectives
1999 Canada To explore “physicians’
perceptions and attitudes and
the decision-making process
associated with prescribing
psychotropic medications for
elderly patients” (p143)
9 physicians (from 12) who
offered medical consultation
in private apartment buildings
for elderly people in a
suburban region of Montreal
Semi-structured interviews Interviews were taped and
transcribed verbatim. Analysis
continued until saturation was
obtained for most categories.
They refer to grounded theory,
but there is insufficient
information to confirm that
they followed this perspective
Principals of
Grounded Theory
Dybwad et al., Why are
some doctors high-
prescribers of benzodiaze-
pines and minor opiates?
A qualitative study of GPs
in Norway
1997 Norway The authors state that they
aimed “to form a basis for
hypotheses and build theories
about prescribing, in order to
investigate how high-
prescribing doctors can
legitimize their own prescrib-
ing pattern” (p361).
18 high-prescribing GPs and
10 medium/low prescribers
Semi-structured interviews. Interviews were audio taped
and transcribed verbatim and
analysed by the interviewer.
Codes were derived from the
data rather than a priori
Phenomenological
GPs completed AUDIT and
estimated their own
prescribing volume.
Observed in the practice
each interview was
conducted in and did a
questionnaire for
respondent characteristics
Parr et al., Views of
general practitioners
and benzodiazepine
users on
benzodiazepines: a
qualitative analysis
2006 Australia To gain a “more detailed
understanding of perceptions
relating to starting, continuing
and stopping benzodiazepine
use” (p1238) from the
perspective of both users and
GPs, and to compare the
views of these groups
Convenience sample of 28
GPs and 23 benzodiazepine
users from a range of
locations in the tropical
holiday and regional centre of
Cairns
Semi-structured interviews Interviews were audio taped
and transcribed verbatim, and
notes were taken during
interviews. The notes were
used for 4 GPs and 2 service
users s due to equipment
failure. Uses the Consensual
Qualitative Research Approach.
The article describes the
different steps, but does not
label them
Unclear
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Table 2 Description of studies included in the review (Continued)
Rogers et al.,
Prescribing
benzodiazepines in
general practice: A new
view of an old problem
2007 UK To give a brief history of the
controversy surrounding
benzodiazepine prescribing. To
report a qualitative study of
recent GP views on the use of
benzodiazepines. To discuss
the outcomes of this study in
relation to “the general
context of psychotropic drug
responses to the psychosocial
features of mental health
problems’” (p182)
Purposive sample of 22 GPs,
15 male and 7 female GPs -
newly qualified practitioners
and GPs who had been prac-
ticing for some time and from
a variety of practice settings
across one English city. Cap-
tured a range of different ages,
but was a bias towards youn-
ger GPs
Semi-structured interviews Interviews were taped and
transcribed. Themes derived
through discussion by 5
researchers, with themes being
modified by reading and re-
reading transcripts
Unclear
Smith, General medical
practitioners and
community pharmacists
in London: Views on the
pharmacist’s role and
responsibilities relating
to benzodiazepines
1993 UK To investigate GP's
perceptions of the roles and
responsibilities of community
pharmacists in relation to
promoting sensible use of
benzodiazepines
Random sample of 22 GPs in
London selected from lists
held by he Family Health
Service Authorities (out of 35
asked to participate)
Semi-structured interviews Interviews were taped and
transcribed. Data were
collected and analysed using a
coding frame.
Unclear
Subelj et al.,
Prescription of
benzodiazepines in
Slovenian family
medicine: a qualitative
study
2010 Slovenia To investigate how high-
prescribing family physicians
explain or justify their prescrib-
ing of benzodiazepines
Random sample of 5 family
physicians with volumes of
prescriptions larger than 4000
defined daily doses per month
and 5 with volumes smaller
than 2000 defined daily doses
per month
Semi-structured interviews Interviews were taped and
transcribed verbatim. Very little
information on how themes
were then derived. There is a
broad description on the
methodology; they probably
used thematic analysis but did
not label it as such
Unclear
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passing nurse prescribing. Seven studies involved semi-
structured interviews and one used focus groups. One
study [24] contained data from benzodiazepine users, and
another included observational and quantitative measures
[25] which were not included in the analysis.
Quality assessment
CASP criteria were independently rated ‘zero’ or ‘one’ by
rater pairs. All papers scored 9 or 10 (out of 10) on
CASP (Table 3). Cohen’s kappa 0.25 indicated initial dis-
crepancy between pairs - this was resolved through dis-
cussion (as detailed above). No studies were excluded
because all met the quality assessment.
Data synthesis
We identified seven analytic themes namely: ‘the chan-
ging context of benzodiazepine prescribing’, ‘the role and
responsibility of the GP’, ‘GP attitudes towards different
interventions’, ‘the ‘deserving’ patient’, ‘perceived patient
expectations’, ‘different challenges faced for managing ini-
tiation and withdrawal’, and ‘ambivalent attitudes towards
prescribing benzodiazepines leading to inconsistent man-
agement strategies for prescribing benzodiazepines’. As
shown by the arrows and the overlap between the shapes
in this figure, there was some interaction between themes.
The latter theme was shaped by a number of processes
underlying prescribing practice which are identified in the
remaining themes and the model (Figure 2) described in
detail below.
The changing context of benzodiazepine prescribing
GPs perceived the context for benzodiazepine prescribing
decisions had changed over time because of changing:
norms of practice, evidence, guidance (national and local),
introduction of new drugs (e.g. selective serotonin reuptake
inhibitors) and services, legal regulatory frameworks and
the societal attitudes for treatment of conditions including
anxiety, depression and insomnia. This changing context,
which (as shown by the overlap in shapes in Figure 2)Table 3 Quality assessment of papers
Authors UK CASP
rating
Belgian
CASP rating
Final joint
CASP rating
Anthierens et al., (2007) 9 10 10
Cook et al., (2007) 9 9 9
Damestoy et al., (1999) 9 9 8
Dybwad et al., (1996) 9 9 9
Parr et al., (2006) 10 10 10
Rogers et al., (2007) 9 10 9
Smith, (1993) 9 10 9
Subelj et al., (2010) 9 9 9underlies many of the other themes identified, included
two key aspects. Firstly, GPs stated being better informed
about risks of benzodiazepines - a historical culture of
prescribing that was optimistic to benefits and naïve
about risks had largely been replaced by an attitude of
scepticism:
“The respondents considered that this early optimistic
therapeutic ethos has now been replaced with one of
cautiousness as indicated by this respondent:
“I think there’s been an interesting change in the last
20 years in that I think you could say that there was a
certain naivety and that if you, if anybody, now that
I’m 50 said to me, ‘Here’s a great drug for anxiety
which people can take long term and doesn’t have any
addictive effects’ I simply wouldn’t believe them. But
the fact was that when I qualified that was what we
believed” [26].
Secondly, GPs now treated more patients, including
those with mental health problems, previously treated in
secondary care:
“While recently psychiatrists predominantly have
focused on the management of psychosis, at the time
of the emergence of the benzodiazepine problem they
would regularly see outpatients with problems of
anxiety and depression who were not, as now,
managed in primary care” [26].
The changing context had influenced how GPs perceived
their role and responsibilities towards their patients.
Role and responsibility of the GP
Some GPs felt a sense of responsibility for past (which
they now considered) poor prescribing practices, whilst
others thought that this negative perception was over-
stated. There was tension between wanting to help pa-
tients, and feeling responsible for minimising BZD use:
“GPs…regarded BZD-prescribing as one of the most
demanding and uncomfortable tasks in their clinical
work. The discomfort was stated as a feeling of doing
something almost illicit with prescribing because of
the restrictive attitudes of both society and of the
health authorities” [25].
“I think in some ways it has gone too far the other
way in that GPs these days can be too afraid to use [a
benzodiazepine]. I mean if the worst thing you can
say about these drugs is that they have a potential for
dependency, I don’t think that is a good enough
reason to withdraw” [26].
Figure 2 Explanatory model based on analytic themes.
Sirdifield et al. BMC Family Practice 2013, 14:191 Page 7 of 13
http://www.biomedcentral.com/1471-2296/14/191GPs varied in the extent to which they accepted re-
sponsibility for past prescribing and/or wished to modify
their practice in light of increasing evidence against
long-term benzodiazepine use; some blamed others for
inappropriate prescribing they had inherited:
“The origin of the problems of over-prescribing and
turning a blind eye to the addictive features of the
drugs were not always accepted as having been the
sole responsibility of GPs; psychiatrists were seen as
the source of the prescription habit. The respondents
were keen to emphasize that a focus on GPs has been
unreasonable, given that the psychiatric profession was
deemed to be responsible for initiating and legitimizing
the use of the drugs” [26].
GPs’ desire to support distressed patients was expressed
as empathy through giving a prescription:“If somebody comes along and says, ‘Here’s a good
drug’ and the patients like it, then people are
tempted to use it because it treats our own pain as
well as our patients’ pain, ‘cos we want to help
people and make people feel better. So if we give
people something and make them feel better, then
everybody seems to be happier” [26].GPs felt responsible for prescribing appropriately but
varied in attitudes to (correcting) ‘past’ prescriptions. In-
dividual GPs often had explicit ‘rules’ about conditions
for which they were willing to prescribe benzodiazepines,
illustrated in the following two patient-related themes.
The ‘deserving’ patient
GPs often managed the tension between minimising
prescribing and their responsibility to help patients on a
case-by-case basis. They needed to justify giving or
withholding benzodiazepines, expressed in the literature
through the concept of the ‘deserving patient’. In one
study [6] participants were reluctant to indicate under
what circumstances they would prescribe; but else-
where, GPs described characteristics of those who might
legitimately use benzodiazepines:“GPs…reported that the majority [were] elderly and
female, and many were continuous users with long
histories of treatment by other doctors. Many of the
continuous users suffered from multiple diseases,
including both somatic and psychiatric disorders,
and often a complexity of psychosocial problems.
Patient[s] (sic) with anxiety and insomnia were
prevalent [25].
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public sympathy whereas:“Undeserving groups were those who do not elicit
sympathy in the public eye and implicated GPs felt
moral and legal responsibility. GPs labelled drug
addicts and alcoholics as ‘undeserving’ patients.
Substance abuse was a key clinical feature to attend to
in decision making” [26].
This translated into different approaches for elderly
compared with younger patients:“A number of physicians appeared to have different
rules and strategies for prescribing these medications
in older versus younger adults, and were more
tolerant of long-term use in the elderly” [6].
GPs often felt greater (or perceived greater public)
sympathy but also felt a lack of alternatives for older
compared with younger patients:
“Physicians thought their older adult patients would
resist or be unable to pursue mental health referrals
for multiple reasons ranging from stigma to financial
and transportation difficulties” [6].
GPs varied in their estimation of the balance of adverse
drug effects, including risk of addiction/abuse, against
potential benefits for older patients:
“In the end, physicians believed that the advantages of
continuing benzodiazepines in the elderly outweighed
the problems” [6].
“Low-prescribers were more aware of cognitive
impairment in the elderly and likelihood of falls and
consecutive hip fractures” [27].
‘Deserving’ patients were also defined in terms of con-
ditions such as bereavement or incurable or complex
problems:
“For continuous prescribing of benzodiazepines and
minor opiates, cure should have been abandoned. The
patient is labelled as ‘beyond cure’ and can be placed
in a ‘side track’, a label that permits palliative
treatment” [25].
Perceived patient expectations
Prescribing was influenced by how doctors perceived
patients’ expectations, motivation and ability to cope.Expectations were sometimes assumed rather than dir-
ectly discussed:
“Physicians anticipated resistance in response to even
broaching the topic of taper/discontinuation with an
older patient. Prospects ranged from questioning the
doctor’s authority and competence, to minimization of
potential negative side effects, to finding another
doctor who was willing to prescribe it” [6].
Some patients were felt to be better able or motivated
to cope without benzodiazepines or engage with alterna-
tive treatments than others:
“…these types of people and they tend not to want to
help themselves, you know they won’t take
hypnotherapy and they won’t go to yoga classes and they
won’t do anything else. They just want a quick fix” [24].
A GP knowing a patient well and/or empathising with
their situation, increased the likelihood of breaking pre-
vious ‘rules’ about what constituted a ‘deserving patient’:
“The following case shows that in some contexts
the normal aversion to offering the drugs to
patients with a drink problem noted earlier can be
overridden by some GPs sympathetic to the
personal plight of some patients: The commonest is
people with those long-term life problems, bad un-
happy marriages, maybe have a partner who’s a
drinker, has a drinking problem themselves. It’s hard
to generalize but, yeah, you know, domestic violence,
dysfunctional relationships, whatever. People end up
on them and stay on them” [26].
GP attitudes towards different interventions
The treatment choices that GPs made in response to
their perceptions of their patients, their patients’ expec-
tations, and their own role and responsibilities were also
influenced by their own attitudes and beliefs about dif-
ferent interventions. This ranged from disbelief that ben-
zodiazepines would solve the patient’s problem to seeing
drugs as the ‘lesser evil’ – particularly for psycho-social
problems:
“A complex psychosocial situation is often the cause of
the distress and the GP feels powerless in such
situations. But the resolution of these problems does not
always belong within the medical sphere; nevertheless,
GPs look for a medical solution and they find BZDs to
be the “lesser evil”: You have to think that if you were in
their situation you would not know what to do either. In
this situation this person needs a BZD to give him some
support for the things that are unbearable” [28].
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effective or ineffective depending on the professional
or personal experience of the GP. Negative attitudes
towards benzodiazepines were based on their perceived
risks:
“The addiction is so well known about that I think we
all would just try and avoid using them for that
reason” [26].
Others viewed the potential for dependence or adverse
effects as less of a problem:
“GPs stated that dependence was not really a problem
for first-time users. BZDs were seen as an efficient,
cheap, and easy option that does not have too many
side-effects” [28].
The ‘fast acting’ and effective nature of benzodiazepines
for some GPs made them preferable to other forms of
treatment:
“Sometimes it’s the easiest choice for people to feel
best quickly. They feel better fast” [6].
Attitudes were also affected by GPs’ personal use of
benzodiazepines:
“Your own attitude towards and experiences of the
product definitely has an effect on prescribing. We,
ourselves, take a lot of benzodiazepines” [28].
GPs perceived a lack of alternative treatments, depend-
ing on their knowledge of alternatives and their views
about validity or effectiveness of non-pharmacological op-
tions for particular patients:
“GPs also feel uncertain how to deal with psychosocial
problems, as a result of insufficient training: I have to
do a lot of “psycho” Whether I want it or not but I
haven’t got the training for it. What do I do? I
prescribe…” [28].
“Scepticism regarding nonpharmacological approaches
to the treatment of conditions such as anxiety and
insomnia was expressed by the physicians interviewed.
They identified common mild alternatives (e.g. warm
milk, not watching violent movies before bed) and
considered them to be ineffective for elderly people
with chronic problems and thought that
psychotherapeutic approaches were “doomed to
failure”. Thus, the decision to prescribe medication
was often seen as the most effective way to help the
patient” [29].In many cases, the alternatives used were ‘pills’ as these
were thought to have benefits including placebo effects:
“GPs looked mainly for alternatives within their medical
sphere. A wide range of medication such as
antidepressants or neuroleptics was seen as an
alternative. Other GPs were more inclined to use plant
extracts because of a lower risk of dependence but at
the same time they acknowledged a placebo effect” [28].
Some alternatives were seen as less ‘valid’ due to in-
accessibility, stigma and costs for patients:
“Issues identified by less than five GPs included the
need for non-stigmatised services; difficulty referring
to other services, especially where there were strin-
gent admission criteria; absence of feedback from
other agencies; limited access to alternate services in
rural and remote areas and a lack of time or resources
to provide counselling, especially due to the absence
of remuneration for doing so” [24].
The greater time GPs required to address patients’
(psychosocial) issues through alternative treatments (and the
lack of remuneration for alternative treatments) compared
with GPs’ view of benzodiazepines as a ‘fast acting’ solution
for both the patient and themselves was another barrier:
“Physicians cited time constraints as both promoting
benzodiazepine use and impeding discontinuation efforts.
A benzodiazepine becomes a quick fix because you don’t
have time, this is what they want, they don’t feel good, here
it is. It numbs them up and you’re not gonna get a phone
call afterwards, you’re not gonna get anything, you’ll see
them in a month, here’s your renewal, see ya later” [6].
Different challenges for managing initiation and
withdrawal
GPs’ attitudes towards benzodiazepine prescribing, and
behaviour, were moderated by the different challenges of
a new prescription, continuing previous treatment or
withdrawing drugs. The context of GPs’ practice, their
view of their role, the perceived risks and effectiveness
of benzodiazepines or alternative treatments, and the pa-
tient all influenced whether or not a GP chose to initiate,
continue or withdraw benzodiazepines. Particular patient
attributes, including old age, multiple conditions, and
being perceived as a ‘deserving patient’ also increased
the pressure to prescribe and gave a rationale to do so:
“being well acquainted with the patient further
reduces the possibility to discontinue the drug, since
they can understand their need for BZD support in
particular situations” [27].
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terventions), or the prospect of unhappy patients leaving
for other practices, influenced whether or not GPs initi-
ated withdrawal:
“She’s been on it for years, I’ll just give her what she
asks for and I won’t have to sit here and explain
things for twenty minutes about why I want to get her
off. ‘Cause it is, it is an effort and time and frustration
trying to get people off of these things. So maybe it’s
just the path of least resistance” [6].
Not all GPs were concerned about the potential loss of
patients:
“I’m not afraid of losing patients. I write a
prescription only if it’s necessary” [27].
Withdrawal was problematic as GPs felt compelled to
provide an alternative to benzodiazepines as well as ap-
plying a withdrawal strategy – something many had ex-
perienced failure with:
“Lacking strategies for both successful taper and
alternative treatment, physicians did not want to
withhold a medication that provided ongoing relief to
the patient” [6].Ambivalent attitudes towards prescribing
benzodiazepines leading to inconsistent strategies for
managing prescribing
Overall, GPs were ambivalent towards prescribing benzo-
diazepines because of the issues described above, ranging
from those who rarely prescribed, to those who did not
see a problem with prescribing benzodiazepines. For most
GPs, located in the middle of this continuum, these were
complex decisions leading to conflicting pressures about
whether or not to prescribe:
“These descriptions were discussed in relation to two
imperatives in tension with one another: the moral
obligation to ensure a programme of humane
withdrawal; and the strict need to restrict access to a
wider population. This tension is managed within the
daily working constraints of GPs” [26].
These pressures led GPs to adopt a variety of manage-
ment strategies from minimising benzodiazepine use to
using tacit or explicit rules (heuristics) to justify prescribing.
Complexity and conflict resulted in inconsistency between
GPs in the strategies employed and how these were applied.
Many GPs stated that they attempted to prescribe small
quantities of benzodiazepines for short periods particularlywhen issuing new prescriptions, advising patients of the
risk of adverse effects:
…I actually tell people when I am giving them a short
course say for a crisis, that I only want you to take
these for 4 or 5 days and then throw the rest of them
away because they are habit forming” [24].
Some GPs saw it as part of their role to wean patients
off drugs:
“A legitimate and expected role of the GP’s role now
is to wean people off drugs to which they had
inadvertently become addicted, for whatever reason,
in the past” [26].
GPs’ tacit and explicit rules about benzodiazepine use
included the following example:
“We do not prescribe BZD any more for people who
have constant anxieties. We prescribe BZD in acute
situations and always within a time limit” [28].
However these self-imposed rules were often inconsist-
ently applied because of conflicting pressures, resulting in
differences in behaviour between different GPs and within
individual GPs’ practice.
Discussion
Main findings
Thematic synthesis enabled us to combine qualitative
studies from different times and locations in a meaning-
ful way to produce a model which clarifies our under-
standing of the complexities, challenges and potential
solutions to primary care benzodiazepine prescribing.
The included papers originated from seven different
countries, with different healthcare systems, but despite
this, themes identified were broadly consistent across
them. GPs were ambivalent towards prescribing benzo-
diazepines and inconsistently applied strategies for man-
aging their use. Not only did different GPs vary in the
extent to which they were willing to prescribe benzodi-
azepines, but individual GPs’ approaches varied. Making
decisions on whether or not to prescribe was often un-
comfortable, demanding and complex within the time
and pressure constraints of daily practice.
GPs perceived a continually changing work context in
which they were increasingly aware of the risks of benzo-
diazepines but more often encountered patients, perhaps
previously managed in secondary care, who might require
them. GPs felt a desire and responsibility to help their pa-
tients and decisions about what form this should take (i.e.
a prescription or a non-pharmacological alternative) was
based on competing and sometimes contradictory factors.
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tions of patients’ expectations of benzodiazepine pre-
scribing competed with GPs rationing role, autonomy,
attitude to benzodiazepines, and wish to maintain good
doctor-patient relationships – sometimes through giving
patients their desired ‘quick-fix’ [30,31]. GPs faced different
challenges during initiation, continuation or withdrawal of
these drugs (Figure 2).
Strengths and weaknesses
This is the first meta-synthesis of qualitative studies of
benzodiazepine prescribing. Qualitative research encom-
passes a broad range of methods and philosophical posi-
tions, and our included studies were heterogeneous in
terms of participants, geographical setting and time.
Consequently, it may be problematic to generalise the
findings and the particularities of a study may be lost in
a meta-synthesis.
We have addressed these potential criticisms by in-
cluding descriptions of each study (Table 2) and explor-
ing the current relevance of the ideas gleaned (see
below). We also employed techniques used for enhan-
cing the validity of primary research studies, for ex-
ample, using multiple investigators and considering the
potential biases that their background might introduce
in the analysis. Moreover, we provided direct quotations
from included papers to ground our interpretation in
the original studies [32] and have considered ‘negative
cases’ within each of our themes. Using this transparent
approach we were able to reach deeper insights into in-
fluences on prescribing and how this might be improved
than could be gained from reading any of the included
papers in isolation.
Findings in relation to other studies
In his critical incident study of uncomfortable prescrib-
ing decisions, Bradley stated, “any attempt to influence
the prescribing behaviour of doctors ought to be based
on a thorough understanding of how prescribing deci-
sions are actually made” [33]. It was the combination of
factors influencing decisions whether or not to prescribe,
rather than any single factor, which made it difficult
[33]. This study similarly highlights tensions in the pro-
cesses underlying decisions about benzodiazepine pre-
scribing explaining why it proves such a difficult task.
GPs often made prescribing decisions in the context of
uncertainty and in the short timescales and pressures of
the consultation. Consequently they sometimes general-
ised from their experience of prescribing and withdraw-
ing patients from benzodiazepines, to assume what
patients’ views of risks and benefits would be - an ex-
ample of Kahneman’s ‘representativeness’ heuristic [34].
Similarly, GPs justified giving a prescription to what has
been described in previous literature as ‘deserving’patients [26,35]: this may be an example of an ‘affect’
heuristic – where the difficult question of ‘should I pre-
scribe’ has been replaced with an easier one of ‘is this a
deserving patient’.
Research on the effect of empathy on decisions made
for others shows that greater empathy with others leads
to more impulsive decisions made for them [36]. Thus,
whereas doctors may, in general, be more conservative
in their decisions for patients than they would be for
themselves, strong feelings of empathy for the patient may
lead doctors to be more likely to offer a prescription.
GPs may also make assumptions about patients’ expec-
tations rather than eliciting them directly, a notion which
has been described previously in relation to antibiotics
[37] and hypnotics [38]. Their attitudes about benzodiaze-
pines and perceptions of the balance between the ease of
prescribing and the risks and benefits may vary with each
patient. Moreover, even when a GP does not believe that
benzodiazepines will be an effective solution, they may still
decide to prescribe due to a belief that there is a lack of
valid alternatives for that patient, or a fear that any at-
tempt to change a patient’s (perceived) preference of drugs
over alternatives would be time-consuming or lead to the
patient seeking another doctor.
The use of heuristics together with contextual limita-
tions in terms of short consultation times, remuneration
for treatment in some countries et cetera may lead to
long-term prescribing contrary to clinical guidelines.
Implications for future practice and research
In building our model of processes underlying current
prescribing practices, we sought to identify ways to im-
prove adherence to current clinical guidance which rec-
ommends use of psychological treatments for insomnia
first-line and short-term use of benzodiazepines only.
This section details our recommendations in relation to
the role that GPs, education/training providers, and ser-
vice providers can play in improving adherence to current
clinical guidance.
Firstly, we ask what GPs can do to improve their ad-
herence to current prescribing guidelines given the ten-
sions and contextual limitations described above. The
metasynthesis has shown that doctors sometimes erro-
neously assumed that patients wanted drug treatment
and/or would be resistant to withdrawal whereas some
patients preferred not to use or wished to discontinue
drugs [8,38]. Such patients wanted to be heard, taken
seriously and given explanations of treatments [38,39].
One way of addressing this issue would be if GPs are
made more aware, through both education and continu-
ing self-reflection, of the impact of empathy and per-
ceived patient expectations on their decision-making;
and encouraged to directly explore patients’ ideas and
expectations and discuss treatment options, explaining
Sirdifield et al. BMC Family Practice 2013, 14:191 Page 12 of 13
http://www.biomedcentral.com/1471-2296/14/191their benefits and drawbacks [38]. Despite constraints of
short appointment times, this approach may lead to re-
duced workload long-term with fewer patients returning
for repeat prescriptions. This potential benefit is some-
thing which could be the subject of future research.
GPs also expressed concerns about the accessibility of
some alternatives to benzodiazepines for some patients.
The legitimacy of this concern could be considered in
future research working with patients to seek feedback
on their perceptions of the accessibility of alternative
treatments and with other professionals, such as mental
health workers and pharmacists [40], to provide such
alternatives.
Secondly, we ask what educational providers can do to
improve GPs’ adherence to current prescribing guidelines.
The papers report mixed findings in terms of GPs’ willing-
ness to engage in further training, particularly due to the
time constraints that they face [27,29]. However, we sug-
gest that there would be a benefit to addressing GPs’
knowledge deficits through increasing education and
training around current guidelines, the adverse effects of
benzodiazepine use, and alternative forms of treatment.
Such training should be targeted at high benzodiazepine
prescribers in particular and should include information
on the evidence for non-pharmacological alternatives such
as face-to-face or self-help (including computerised) cog-
nitive behavioural therapy for insomnia (CBT-I). In
addition, it should raise GPs’ awareness of the impact of
empathy and perceived patient expectations on decision-
making as outlined above.
Finally, we feel that there is a clear role for service
providers in improving adherence to current prescribing
guidelines in the long-term by increasing the availability
and accessibility of face-to-face and computerised
CBT-I.
Further primary research may be needed to confirm
these findings, and a fuller understanding of the dynamics
of benzodiazepine prescribing decisions should also con-
sider patients’ perceptions.Conclusion
Benzodiazepine prescribing decisions in primary care are
complex, demanding and uncomfortable. This study has
increased our understanding of why this is so and has
the potential to inform future interventions to improve
adherence to prescribing guidance and improve pre-
scribing of benzodiazepines through enhanced education
and training of professionals on benzodiazepine use and
withdrawal, greater provision of alternatives to drugs, re-
flective practice, and better communication with pa-
tients. Finally, our findings have wider implications for
difficult prescribing decisions since similar issues often
apply to other prescribing contexts.Competing interests
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